Tranexamic acid injection effect at laparoscopic cystectomy

Evalution of tranexamic acid injection effect at laparoscopic cystectomy on AMH level in endometrioma patient

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201208049652N1

Enrollment

Registered

2021-02-15

Start date

2019-09-23

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis , Laparoscopy. Endometriosis

Interventions

Intervention 1: Intervention group: Cystectomy with tranexamic acid injection. Patients are randomly assigned to two groups of routine cystectomy without injection of tranexamic acid (A) and the grou

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients between 18-40 years old with regular menstruation and endometrioma Unilateral endometrioma cyst with 4-10 cm

Exclusion criteria

Exclusion criteria: History of previous ovarian surgery and pelvic adhesion History of previous endocrinology diseases (Diabetes, Hyperprolactinoma ) PID History of previous chemotherapy History of previous PTE Cyst other than endometrioma intraoperative Cigarette Smoking , OCP consumption Severe Renal Disease Tranexamic acid injection contraindication

Design outcomes

Primary

Measure	Time frame
Antimullerian Hormone Level. Timepoint: 3 , 6 month. Method of measurement: ng/ml.	—

Secondary

Measure	Time frame
Antimullerian Hormone Level. Timepoint: 3 , 6 month. Method of measurement: ng/ml.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Razavi

Zahedan University of Medical Sciences

dr.razavi351@gmail.com+98 54 3329 5570

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026